Early effects of intravitreal anti-VEGF agents on cornea and visual acuity in patients with diabetic retinopathy.

Cutaneous and ocular toxicology(2023)

Cited 1|Views3
No score
Abstract
Intravitreal administration of anti-VEGF agents could cause a small but significant greater increase in CCT in PDR than in NPDR eyes in the early period. In patients with DR, no significant difference was found between conbercept and ranibizumab in the early effects on the visual acuity nor in the cornea.
More
Translated text
Key words
Diabetic retinopathy, conbercept, ranibizumab, corneal central thickness, corneal edema, proliferative diabetic retinopathy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined